New whitepaper now available. Download now ›

News & Insights

At OmniScience, we believe in the power of information to inspire, educate, and unite. Explore diverse topics and read about our thoughts on the world of data science.

Recent Posts

News

OmniScience Inc. and INmune Bio Inc. Partner to Accelerate a Phase 2 Alzheimer’s Trial with Vivo, a Novel genAI Clinical Trial Control Tower

HOUSTON & BOCA RATON, Fla. - OmniScience and INmune Bio (NASDAQ: INMB) today announced a pioneering partnership to revolutionize operations for INmune Bio’s global Phase 2 Alzheimer’s disease (AD) clinical trial (the “AD02 trial”) using OmniScience’s flagship product, Vivo, an industry-first, genAI-powered control tower designed specifically for centralizing and analyzing vast clinical data in real time. This solution represents an innovative approach to clinical research, delivering immediate insights that enhance decision-making and transform traditional, time-consuming trial management.

News

OmniScience’s clinical trial genAI-powered control tower, Vivo, wins 1st place in the CNS Summit 2024 Innovation Showcase

Patients are waiting: The CNS Summit brings together life sciences leaders who aren’t afraid to challenge the status quo when it comes to the development of new treatments for patients

Kris Kuhner Joins OmniScience as Senior Vice President of Business Development

Vivo, OmniScience’s genAI-powered clinical trial control tower, wins 2024 The Whale Tank competition at Innovation Network Gathering

Revolutionizing Pediatric Mental Health Monitoring: futuresTHRIVE Licenses OmniScience’s Vivo for Early Detection in Children

Revolutionize Trial Oversight with genAI: On-Demand Insights to Improve Clinical Trial Success

Eliminate the Wait: Real-Time Data Drives Faster, Smarter Trials

Accelerating Adoption of DHTs within Clinical Trials: Lowering the Barrier of Entry Through Data Unification

Advancing Digital Endpoints in Clinical Trials: OmniScience Announces Strategic Partnership with DiMe

Navigating the Biotech Landscape: A Deep Dive into Knowledge Graphs for Market Insight

From Disparate Data to a Cohesive Narrative: Why Clinical Trial Data Unification is a Strategic Imperative

From Fragmentation to Fusion: Rethinking Information Access in Clinical Trials

Unlocking the Power of Genetic Algorithms: A Revolution in Precision Diagnostics

Mercury Data Science Unveils New Identity as OmniScience: A Vision for the Future

The Evolving Role of Generative AI in the Life Sciences Industry

Leveraging Knowledge Graphs in Life Sciences: Accelerate Discoveries and Improve Patient Outcomes

Navigating Data Security in the Age of Large Language Models (LLMs)

OmniScience Welcomes Michael Bell, Ph.D. as Vice President of Platforms

Revolutionizing Clinical Trials: How AI is Improving Clinical Trial Retention

Understanding Digital Biomarkers in Life Sciences for Biotech and Pharma

Unleash the Potential of Large Language Models (LLMs) in Life Sciences

ANCP poster abstract publication with Janssen

Extract Intelligence from the Biomedical Black Hole to Accelerate Discovery

Natural Language Processing in Life Sciences and Healthcare: Create more predictive ML models

OmniScience Appoints Angela Holmes as CEO

The Case for Video AI in Telemedicine